Consuming 60 grams of nuts a day improves sexual function
Researchers from the Human Nutrition Unit of the Universitat Rovira i Virgili (Tarragona/Spain) and the Pere Virgili Health Research Institute […]
» Read more(HealthDay)—For patients with osteoarthritis (OA) of the knee or hip, tanezumab is associated with significant improvements in pain and physical […] Scientists at UC San Francisco have developed a personalized digital meditation training program that significantly improved attention and memory in […] Even after decades of research, cancer remains difficult to treat, in part because of its ability to evade the body’s […] Adoptive cell transfer (ACT) is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable […] Before patients receive intravenous (IV) antimicrobial infusion therapy outside of the hospital—whether at home, a doctor’s office or a skilled […] A study led by St. Michael’s Hospital researchers, and presented at a prestigious late-breaker session at the American Heart Association […] Treating the prostate with radiotherapy alongside standard treatment led to an 11 per cent increase in survival for some men […] Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free […] In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP […]
Tanezumab improves scores for pain, function in osteoarthritis
Personalized digital meditation training program improves attention and memory in healthy young adults
Innovative drug delivery improves effectiveness of cancer immunotherapy
Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
ID specialist input improves outcomes for outpatient parenteral antimicrobial therapy
Study suggests diabetes medication improves heart structure
Cancer trial shows treating the prostate with radiotherapy improves survival
Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer
PARP inhibitor improves progression-free survival in patients with advanced breast cancers
